Mindray Medical International Limited (NYSE:MR) will hold a conference call on March 5 at 8:00 pm to discuss the fourth quarter earnings for 2007.
Mindray Medical develops, manufactures and markets medical
devices in
The company received a 510 clearance from the United States Food and Drug Administration (FDA) in June 2007, for its automatic three-part differential hematology analyzer, BC-3200 and its central monitoring system, Hypervisor VI.
Mindray also acquired 8.9% of the minority interest in Shenzhen Mindray Bio-Medical Electronics Co Ltd on April 20, 2006.
For more Conference Call related events or to post your own event, visit: